Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001337490 | SCV001531093 | likely benign | Acromesomelic dysplasia 1, Maroteaux type; Tall stature-scoliosis-macrodactyly of the great toes syndrome | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004035835 | SCV004992508 | uncertain significance | Inborn genetic diseases | 2021-08-13 | criteria provided, single submitter | clinical testing | The c.3119G>A (p.R1040Q) alteration is located in exon 22 (coding exon 22) of the NPR2 gene. This alteration results from a G to A substitution at nucleotide position 3119, causing the arginine (R) at amino acid position 1040 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |